These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17704152)

  • 21. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of chloride interaction with neurotransmitter:sodium symporters.
    Zomot E; Bendahan A; Quick M; Zhao Y; Javitch JA; Kanner BI
    Nature; 2007 Oct; 449(7163):726-30. PubMed ID: 17704762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of the Binding of Octopamine and Dopamine in Insect Monoamine Transporters Reveals Structural and Electrostatic Differences.
    Arancibia S; Marambio M; Campusano JM; Fierro A
    ACS Chem Neurosci; 2019 May; 10(5):2310-2317. PubMed ID: 30605598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling study of the editing active site of Escherichia coli leucyl-tRNA synthetase: two amino acid binding sites in the editing domain.
    Lee KW; Briggs JM
    Proteins; 2004 Mar; 54(4):693-704. PubMed ID: 14997565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.
    Adeniran C; Yuan Y; Davis SE; Lin C; Xu J; Zhu J; Zhan CG
    ACS Chem Neurosci; 2021 May; 12(9):1519-1527. PubMed ID: 33886267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling.
    Hobrath JV; Wang S
    J Med Chem; 2006 Jul; 49(15):4470-6. PubMed ID: 16854052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 with substrates and inhibitors by molecular modeling and dynamics simulation.
    Hamza A; Abdulhameed MD; Zhan CG
    J Phys Chem B; 2008 Jun; 112(24):7320-9. PubMed ID: 18476739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
    Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling side-chains using molecular dynamics improve recognition of binding region in CAPRI targets.
    Camacho CJ
    Proteins; 2005 Aug; 60(2):245-51. PubMed ID: 15981253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docking and homology modeling explain inhibition of the human vesicular glutamate transporters.
    Almqvist J; Huang Y; Laaksonen A; Wang DN; Hovmöller S
    Protein Sci; 2007 Sep; 16(9):1819-29. PubMed ID: 17660252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive atlas of the topography of functional groups of the dopamine transporter.
    Volz TJ; Schenk JO
    Synapse; 2005 Nov; 58(2):72-94. PubMed ID: 16088952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the N-terminal dynamics on the conformational states of human dopamine transporter.
    Xu L; Chen LY
    Biophys Chem; 2022 Apr; 283():106765. PubMed ID: 35101818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
    Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
    Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport.
    Dwyer DS
    Proteins; 2001 Mar; 42(4):531-41. PubMed ID: 11170207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homology modeling and molecular dynamics study of GSK3/SHAGGY-like kinase.
    Xiao JF; Li ZS; Sun M; Zhang Y; Sun CC
    Comput Biol Chem; 2004 Jul; 28(3):179-88. PubMed ID: 15261148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in protein-protein docking: atomic resolution predictions in the CAPRI experiment using RosettaDock with an improved treatment of side-chain flexibility.
    Schueler-Furman O; Wang C; Baker D
    Proteins; 2005 Aug; 60(2):187-94. PubMed ID: 15981249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB; Schwede T; Zoete V; Meuwly M
    Proteins; 2006 Nov; 65(2):407-23. PubMed ID: 16941468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulation of conformational changes occurring when a protein interacts with its receptor.
    Costantini S; Colonna G; Facchiano AM
    Comput Biol Chem; 2007 Jun; 31(3):196-206. PubMed ID: 17500035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.